The writer warns that unapproved peptides can carry risks for users when testing and quality controls fall short, even as use keeps climbing.
Recap by typeshit. Full story at Newsweek on MSN.
Dr. Nadolsky, an obesity medicine doctor, gives his take on a recent GLP-1 warning in a short clip. Tap through to see which warning he means.
14:36
A short look at the less discussed side effects of the experimental weight loss shot retatrutide, which is still in trials and not approved.
2:12
A short explainer on the experimental injection people call Reta, covering why it went viral and what is known so far about its safety.
A nationwide recall now covers a GLP-1 injectable. The full story names the affected medication and explains why it was pulled.
A new 'In Discussion With' episode featuring Sehar Shahid on the pace of weight loss with GLP-1 receptor agonists. Few details shared beyond the topic.
Food makers are leaning hard on protein branding as shoppers chase weight loss, and 7NEWS points to another trend now rising alongside it.
Loading…